Female Menopause and Male Hypogonadism: What have we learned?

Wednesday, 19th June 2019

19:00 (60 mins)


This session focuses on the role of hormones in the female menopause and in male hypogonadism. Whilst the former is readily recognised and treated, the latter is not.

  • Debunking the Myth of Andropause
  • How to identify symptoms and signs of Menopause and Male Hypogonadism
  • Treatment options for the Menopause and Male Hypogonadism
  • Interactive patient case studies


Dr Diana Mansour

Consultant in Community Gynaecology and Reproductive Health

Head of Clinical Service for Sexual Health

Newcastle upon Tyne, UK

Dr Diana Mansour is a Consultant in Community Gynaecology and Reproductive Healthcare and Head of Clinical Service for Sexual Health in Newcastle upon Tyne, UK. She also has been an Associate Clinical Lecturer at Newcastle University since 1997.

In addition, Dr Mansour is Senior Vice President and Trustee for the Faculty of Sexual and Reproductive Healthcare of the Royal College of Obstetricians and Gynaecologists. Dr Mansour is also the Lead Officer for FSRH Clinical Standards Committee, Clinical Effectiveness Committee, the FSRH Clinical Studies Group and FSRH Journal. She sits on the FSRH Finance and Investments Committee and Board of Trustees.

Dr Mansour is the first author to cover 90 peer-reviewed publications. She has recently co-written a textbook for general practice and RCOG trainees with Dr Laura Percy and it is entitled 'Contraception Made Easy'.

Dr Mansour's areas of expertise include acceptability of contraceptive methods, non-contraceptive benefits of contraception, development of long-term methods of contraception, medical management of heavy menstrual bleeding, menopause and hormone replacement therapy.

Dr Jonny Coxon

GP Partner

Beaconsfield Medical Practice

Brighton, UK

Dr Coxon qualified in 1997, at Oxford University. He has been a GP partner in Brighton since 2009. He also works one day a week as a Clinical Assistant in Urology, for Brighton and Sussex Universities NHS Trust, and one day as a Speciality Doctor in the Gender Identity Clinic in London. In addition, he runs a Gender and Sexual Medicine clinic at the Nuffield Health Hospital in Brighton.

Before switching to general practice, he pursued a Urology career path, mainly as a Research Fellow at St George’s Hospital. Alongside clinical work, his prostate cancer research was published in the British Journal of Urology amongst other publications and led to an MD thesis. He also worked in a team carrying out several trials on medications for erectile dysfunction.

He has also completed an extensive training programme under the European School of Sexual Medicine and acquired his Fellowship of the European Committee of Sexual Medicine (FECSM) qualification. He is President of the British Society for Sexual Medicine Association and Secretary of the Primary Care Urological Society. He sits on the committee of the Primary Care Testosterone Advisory Group, and on the editorial board for the journal Trends in Urology & Men’s Health.

Dr Coxon has spoken regularly for the charity Prostate Cancer UK at Primary Care Masterclasses around the country and given presentations on aspects of prostate disease and sexual medicine at various other events across the UK.

Dr Richard Quinton

Consultant Endocrinologist

Newcastle upon Tyne Hospitals NHS Foundation Trust


Dr Richard Quinton qualified from Cambridge University in 1988 and completed his postgraduate training in London. He also spent a year in The Netherlands on the exchange programme. He is a consultant physician in the Newcastle Endocrine unit, prior to which he was appointed as a Consultant to NuTH in 1999.

He is a Fellow of the Royal College of Physicians and a Member of the British, European and American Endocrine Societies, and have strong links with several patient support groups. He also holds the post of Senior Lecturer at Newcastle University’s Institute for Genetic Medicine.

Dr Quinton is a very active professional in medical research and has authored some 80 publications, along with a prize-winning doctoral (MD) thesis. Married to a Consultant Radiologist and have three young children, he is very fluent in French and Italian and reasonably coherent in German and Dutch.

Register now

Restore the man is organised and funded by Bayer and may contain some promotional content.

Licensed for:
In the UK, Nebido® (testosterone undecanoate) is Licensed for testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.

This website is intended for Healthcare Professionals resident in the UK.